Nilsine Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Nilsine Partners's LLY Position: Q2 2026 in Review
Nilsine Partners increased its Eli Lilly (LLY) stake by 0.06% in Q2 2026, buying an estimated $7.15K and bringing the position to 11,082 shares worth $13.3M. The position accounts for 0.92% of the portfolio, ranked #18.
Nilsine Partners first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Nilsine Partners held 11,082 shares of Eli Lilly worth $13.3M as of Q2 2026.
- Nilsine Partners bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 0.92% of Nilsine Partners's portfolio in Q2 2026, its #18 holding.
- Nilsine Partners first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.